Transdermal patches: a recent approach to new drug delivery system S Dhiman, TG Singh, AK Rehni Int J Pharm Pharm Sci 3 (5), 26-34, 2011 | 231 | 2011 |
Role of phosphoinositide 3-kinase in ischemic postconditioning-induced attenuation of cerebral ischemia-evoked behavioral deficits in mice AK Rehni, N Singh Pharmacological reports 59 (2), 192, 2007 | 130 | 2007 |
Amniotic fluid derived stem cells ameliorate focal cerebral ischaemia-reperfusion injury induced behavioural deficits in mice AK Rehni, N Singh, AS Jaggi, M Singh Behavioural brain research 183 (1), 95-100, 2007 | 112 | 2007 |
Ion exchange resins: Drug delivery and therapeutic applications I Singh, AK Rehni, R Kalra, G Joshi, M Kumar, HY Aboul-Enein Fabad Journal of Pharmaceutical Sciences 32 (2), 91, 2007 | 111 | 2007 |
Tramadol‐induced seizurogenic effect: a possible role of opioid‐dependent γ‐aminobutyric acid inhibitory pathway AK Rehni, I Singh, M Kumar Basic & clinical pharmacology & toxicology 103 (3), 262-266, 2008 | 108 | 2008 |
Pharmacological preconditioning of the brain: a possible interplay between opioid and calcitonin gene related peptide transduction systems. AK Rehni, TG Singh, AS Jaggi, N Singh Pharmacological Reports 60 (6), 904, 2008 | 96 | 2008 |
Tramadol-induced seizurogenic effect: a possible role of opioid-dependent histamine (H1) receptor activation-linked mechanism AK Rehni, TG Singh, N Singh, S Arora Naunyn-Schmiedeberg's archives of pharmacology 381, 11-19, 2010 | 85 | 2010 |
Impact of hypoglycemia on brain metabolism during diabetes AK Rehni, KR Dave Molecular neurobiology 55 (12), 9075-9088, 2018 | 78 | 2018 |
Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors D Della-Morte, R Palmirotta, AK Rehni, D Pastore, B Capuani, F Pacifici, ... Pharmacogenomics 15 (16), 2063-2082, 2014 | 77 | 2014 |
Opioid withdrawal syndrome: emerging concepts and novel therapeutic targets A K Rehni, A S Jaggi, N Singh CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2013 | 75 | 2013 |
Carbon nanotubes: synthesis, properties and pharmaceutical applications I Singh, AK Rehni, P Kumar, M Kumar, HY Aboul‐Enein Fullerenes, Nanotubes and Carbon Nanostructures 17 (4), 361-377, 2009 | 70 | 2009 |
Effect of chlorophyll and aqueous extracts of Bacopa monniera and Valeriana wallichii on ischaemia and reperfusion-induced cerebral injury in mice AK Rehni, HS Pantlya, R Shri, M Singh CSIR, 2007 | 59 | 2007 |
Hyperglycemia/hypoglycemia-induced mitochondrial dysfunction and cerebral ischemic damage in diabetics AK Rehni, N Nautiyal, MA Perez-Pinzon, KR Dave Metabolic brain disease 30, 437-447, 2015 | 55 | 2015 |
Gastroretentive: a controlled release drug delivery system S Dhiman, TG Singh, AK Rehni, S Sood, S Arora Asian J Pharm Clin Res 4 (SUPPL 1), 5-13, 2011 | 50 | 2011 |
Pharmacological inhibition of inducible nitric oxide synthase attenuates the development of seizures in mice AK Rehni, TG Singh, R Kalra, N Singh Nitric Oxide 21 (2), 120-125, 2009 | 49 | 2009 |
Possible involvement of insulin, endogenous opioids and calcitonin gene related peptide in remote ischaemic preconditioning of brain AK Rehni, N Singh, AS Jaggi Yakugaku zasshi 127 (6), 1013-1020, 2007 | 48 | 2007 |
Dendrimers and their pharmaceutical applications–a review I Singh, AK Rehni, R Kalra, G Joshi, M Kumar Die Pharmazie-An International Journal of Pharmaceutical Sciences 63 (7 …, 2008 | 47 | 2008 |
Remote ischaemic preconditioning and prevention of cerebral injury AK Rehni, R Shri, M Singh CSIR, 2007 | 47 | 2007 |
Reviving mitochondrial bioenergetics: a relevant approach in epilepsy S Singh, TG Singh, AK Rehni, V Sharma, M Singh, R Kaur Mitochondrion 58, 213-226, 2021 | 44 | 2021 |
Involvement of CCR-2 chemokine receptor activation in ischemic preconditioning and postconditioning of brain in mice AK Rehni, TG Singh Cytokine 60 (1), 83-89, 2012 | 40 | 2012 |